Showing results (201-210 of 227) with videos related to

Sort By:
Pageof 23
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 12, 2009
Glutaminase-deficient mice display hippocampal hypoactivity, insensitivity to pro-psychotic drugs and potentiated latent inhibition: relevance to schizophreniaInna Gaisler-Salomon, Gretchen M Miller, Nao Chuhma, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 13, 2025
PP2A methylesterase, PME-1, and PP2A methyltransferase, LCMT-1, control sensitivity to impairments caused by injury-related oligomeric tauSowmya N Sundaresh, Edward W Vogel, Christopher D Hue, et al.
Plos One|July 11, 2013
Development of Novel In Vivo Chemical Probes to Address CNS Protein Kinase Involvement in Synaptic DysfunctionD Martin Watterson, Valerie L Grum-Tokars, Saktimayee M Roy, et al.
Frontiers in Pharmacology|July 12, 2019
Fluoxetine and Vortioxetine Reverse Depressive-Like Phenotype and Memory Deficits Induced by Aβ1-42 Oligomers in Mice: A Key Role of Transforming Growth Factor-β1Sebastiano Alfio Torrisi, Federica Geraci, Maria Rosaria Tropea, et al.
Aging Cell|September 5, 2024
Blockade of dopamine D3 receptors improves hippocampal synaptic function and rescues age-related cognitive phenotypeMaria Rosaria Tropea, Marcello Melone, Domenica Donatella Li Puma, et al.
Functional Neurology|June 24, 2004
Cortical silent period prolongation in spinocerebellar ataxia type 2 (SCA2)Domenico A Restivo, Sara Lanza, Salvatore Giuffrida, et al.
Pageof 23